GMAB Reports $896M Revenue, $181M YoY Growth, FDA Approves sBLA, $742M Royalties, $237M Op Profit Ex Items
Genmab A/S ADS · Now $25.45
-2.5% in 7d after detection
Post-detection moves
1h
—
1d
-2.3%
3d
+0.1%
7d
-2.5%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS